Examining 7 years of implementing quality management systems in medical laboratories in sub-Saharan Africa.

ISO15189 SLIPTA SLMTA accreditation quality assurance quality management system

Journal

Tropical medicine & international health : TM & IH
ISSN: 1365-3156
Titre abrégé: Trop Med Int Health
Pays: England
ID NLM: 9610576

Informations de publication

Date de publication:
02 2023
Historique:
pubmed: 9 12 2022
medline: 8 2 2023
entrez: 8 12 2022
Statut: ppublish

Résumé

Achievement of ISO15189 accreditation demonstrates competency of a laboratory to conduct testing. Three programmes were developed to facilitate achievement of accreditation in low- and middle-income countries: Strengthening Laboratory Management Towards Accreditation (SLMTA), Stepwise Laboratory Improvement Process Towards Accreditation (SLIPTA) and Laboratory Quality Stepwise Implementation (LQSI). To determine the level of accreditation and associated barriers and facilitators among medical laboratories in the WHO-AFRO region by 2020. A desk review of SLIPTA and SLMTA databases was conducted to identify ISO15189-accredited medical laboratories between January 2013 and December 2020. Data on access to the LQSI tool were extracted from the WHO database. Facility and country characteristics were collected for analysis as possible enablers of accreditation. The chi-square test was used to analyse differences with level of significance set at <0.05. A total of 668 laboratories achieved accreditation by 2020 representing a 75% increase from the number in 2013. Accredited laboratories were mainly in South Africa (n = 396; 55%) and Kenya (n = 106; 16%), two countries with national accreditation bodies. About 16.9% (n = 113) of the accredited laboratories were registered for the SLIPTA programme and 26.6% (n = 178) for SLMTA. Approximately 58,217 LQSI users were registered by December 2020. Countries with a higher UHC index for access to HIV care and treatment, higher WHO JEE scores for laboratory networks, a larger number of registered LQSI users, with national laboratory policy/strategic plans and PEPFAR-priority countries were more likely to have an accredited laboratory. Of the 475 laboratories engaged in the SLIPTA programme, 154 attained ≥4 SLIPTA stars (ready to apply for accreditation) and 113 achieved ISO 15189 accreditation, with 96 enrolled into the SLMTA programme. Lower-tier laboratories were less likely to achieve accreditation than higher-tier laboratories (7.7% vs. 30%) (p < 0.001). The probability of achieving ISO 15189 accreditation (19%) was highest during the first 24 months after enrolment into the SLIPTA programme. To sustainably anchor quality improvement initiatives at facility level, national approaches including access to a national accreditation authority, adoption of national quality standards and regulatory frameworks are required.

Sections du résumé

BACKGROUND
Achievement of ISO15189 accreditation demonstrates competency of a laboratory to conduct testing. Three programmes were developed to facilitate achievement of accreditation in low- and middle-income countries: Strengthening Laboratory Management Towards Accreditation (SLMTA), Stepwise Laboratory Improvement Process Towards Accreditation (SLIPTA) and Laboratory Quality Stepwise Implementation (LQSI).
OBJECTIVE
To determine the level of accreditation and associated barriers and facilitators among medical laboratories in the WHO-AFRO region by 2020.
METHODS
A desk review of SLIPTA and SLMTA databases was conducted to identify ISO15189-accredited medical laboratories between January 2013 and December 2020. Data on access to the LQSI tool were extracted from the WHO database. Facility and country characteristics were collected for analysis as possible enablers of accreditation. The chi-square test was used to analyse differences with level of significance set at <0.05.
RESULTS
A total of 668 laboratories achieved accreditation by 2020 representing a 75% increase from the number in 2013. Accredited laboratories were mainly in South Africa (n = 396; 55%) and Kenya (n = 106; 16%), two countries with national accreditation bodies. About 16.9% (n = 113) of the accredited laboratories were registered for the SLIPTA programme and 26.6% (n = 178) for SLMTA. Approximately 58,217 LQSI users were registered by December 2020. Countries with a higher UHC index for access to HIV care and treatment, higher WHO JEE scores for laboratory networks, a larger number of registered LQSI users, with national laboratory policy/strategic plans and PEPFAR-priority countries were more likely to have an accredited laboratory. Of the 475 laboratories engaged in the SLIPTA programme, 154 attained ≥4 SLIPTA stars (ready to apply for accreditation) and 113 achieved ISO 15189 accreditation, with 96 enrolled into the SLMTA programme. Lower-tier laboratories were less likely to achieve accreditation than higher-tier laboratories (7.7% vs. 30%) (p < 0.001). The probability of achieving ISO 15189 accreditation (19%) was highest during the first 24 months after enrolment into the SLIPTA programme.
CONCLUSION
To sustainably anchor quality improvement initiatives at facility level, national approaches including access to a national accreditation authority, adoption of national quality standards and regulatory frameworks are required.

Identifiants

pubmed: 36480459
doi: 10.1111/tmi.13839
pmc: PMC10108081
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

126-135

Informations de copyright

© 2022 The Authors Tropical Medicine & International Health Published by John Wiley & Sons Ltd.

Références

Am J Clin Pathol. 2010 Sep;134(3):393-400
pubmed: 20716795
Afr J Lab Med. 2014;3(2):216
pubmed: 26753130
Afr J Lab Med. 2022 May 31;11(1):1614
pubmed: 35747559
Afr J Lab Med. 2014;3(3):
pubmed: 26752335
Am J Clin Pathol. 2009 Jun;131(6):774
pubmed: 19461081
Am J Clin Pathol. 2010 Sep;134(3):359-60
pubmed: 20716789
Am J Clin Pathol. 2010 Sep;134(3):401-9
pubmed: 20716796
Afr J Lab Med. 2014;3(2):239
pubmed: 27453824
Am J Clin Pathol. 2010 Oct;134(4):550-5
pubmed: 20855635
Trop Med Int Health. 2023 Feb;28(2):126-135
pubmed: 36480459
Am J Clin Pathol. 2014 Jun;141(6):791-5
pubmed: 24838322
Afr J Lab Med. 2020 Sep 21;9(2):1103
pubmed: 33102173
Afr J Lab Med. 2016 May 20;5(1):280
pubmed: 28879103

Auteurs

Collins O Odhiambo (CO)

African Society for Laboratory Medicine, Addis Ababa, Ethiopia.

Beatrice van der Puije (B)

African Society for Laboratory Medicine, Addis Ababa, Ethiopia.

Michael Maina (M)

African Society for Laboratory Medicine, Addis Ababa, Ethiopia.

Teferi Mekonen (T)

African Society for Laboratory Medicine, Addis Ababa, Ethiopia.

Samba Diallo (S)

African Society for Laboratory Medicine, Addis Ababa, Ethiopia.
Laboratory Division, Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.

Tjeerd Datema (T)

Datos B.V. Leiden, Leiden, The Netherlands.

Marguerite M Loembe (MM)

African Society for Laboratory Medicine, Addis Ababa, Ethiopia.
Laboratory Division, Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.

Yenew Kebede (Y)

Laboratory Division, Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.

Nqobile Ndlovu (N)

African Society for Laboratory Medicine, Addis Ababa, Ethiopia.

Pascale Ondoa (P)

African Society for Laboratory Medicine, Addis Ababa, Ethiopia.
Amsterdam Institute for Global Health and Development, Department of Global Health, University of Amsterdam, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH